Mihalis Kariolis
24Patents
6h-index
35Co-inventors
65Inventor score
Filing activity: Nov 2, 2010 → Mar 17, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8618254B2 | Inhibition of AXL signaling in anti-metastatic therapy | Chemistry; Metallurgy | 22 | Active |
| US10457717B2 | Engineered polypeptides | Chemistry; Metallurgy | 10 | Active |
| US10870837B2 | Fusion proteins comprising enzyme replacement therapy enzymes | Chemistry; Metallurgy | 9 | Active |
| US11124567B2 | Anti-TREM2 antibodies and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US10588938B2 | Receptor-based antagonists of the programmed cell death 1 (PD-1) pathway | Human Necessities | 7 | Active |
| US9074192B2 | Inhibition of AXL signaling in anti-metastatic therapy | Physics | 6 | Active |
| US8778888B2 | Cystine knot peptides binding to alpha IIb beta 3 integrins and methods of use | Human Necessities | 4 | Active |
| US9879061B2 | Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis | Physics | 3 | Active |
| US9266947B2 | Inhibition of AXL signaling in anti-metastatic therapy | Chemistry; Metallurgy | 3 | Active |
| US9822347B2 | Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy | Chemistry; Metallurgy | 2 | Active |
| US11884944B2 | Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof | Chemistry; Metallurgy | 2 | Active |
| US10876176B2 | Antifibrotic activity of GAS6 inhibitor | Chemistry; Metallurgy | 2 | Active |
| US11912778B2 | Methods of engineering transferrin receptor binding polypeptides | Chemistry; Metallurgy | 2 | Active |
| US11795232B2 | Engineered transferrin receptor binding polypeptides | Chemistry; Metallurgy | 2 | Active |
| US11866742B2 | Fusion proteins comprising enzyme replacement therapy enzymes | Chemistry; Metallurgy | 2 | Active |
| US12162948B2 | Methods of engineering transferrin receptor binding polypeptides | Chemistry; Metallurgy | 1 | Active |
| US11498952B2 | Fusion proteins comprising an engineered knottin peptide and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10844106B2 | Fusion proteins comprising an engineered knottin peptide and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12378540B1 | Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof | Chemistry; Metallurgy | 0 | Active |
| US12240882B2 | Fusion proteins comprising an engineered knottin peptide and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11400133B2 | Receptor-based antagonists of the programmed cell death 1 (PD-1) pathway | Human Necessities | 0 | Active |
| US11136563B2 | Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy | Chemistry; Metallurgy | 0 | Active |
| US11732023B2 | Engineered polypeptides | Chemistry; Metallurgy | 0 | Active |
| US11498955B2 | SPD-1 variant# FC fusion proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.